Clover Health Investments, Corp. CLOV
Set alert
At close · Oct 30
After hours · Oct 30, 7:57 PM ET
- YTD
- +89.79%
- 1 year
- +28.53%
- Open
- 4.53
- Prev close
- 4.58
- Mkt cap
- 2.37B
- Vol
- 4.65M
- Avg vol
- 4.19M
- EPS
- -0.05
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.35
- High
- 4.57
- Forward P/E
- 29.73
- Beta
- 2.46
- Short ratio
- 5.73
- Inst. own
- 33.92%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 4.50
- 200-d avg
- 3.53
- 1y target
- 5.50
MAX chart
Events in this range
- Aug 23, 2021Dividend: 0.1
- Aug 5, 2025Earnings: -0.02; estimate -0.00923; surprise -116.68%
- Nov 4, 2025Earnings: -0.05; estimate 0.02; surprise -350%
- Feb 26, 2026Earnings: -0.05; estimate -0.10212; surprise 51.04%
- Mar 20, 2026Rating: Canaccord Genuity · Buy → Buy
- May 6, 2026Earnings: 0.07; estimate 0.07; surprise 0%
- Jun 4, 2026Rating: Canaccord Genuity · Buy → Buy
- Jun 11, 2026Rating: UBS · Neutral → Neutral
- Jul 21, 2026Rating: Canaccord Genuity · Buy → Buy
- Aug 5, 2026Earnings: 0.05; estimate 0.03864; surprise 29.4%
- Aug 6, 2026Rating: UBS · Neutral → Neutral
- Oct 28, 2026Rating: Needham · — → Buy
- Nov 4, 2026Earnings: —; estimate -0.00507; surprise —%
Signals (95)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 1 day ago |
| SMA: Bullish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 7, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 2 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| RSI: Overbought | May 18, 2026 | 5 months ago |
| SMA: Bullish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 19, 2026 | 9 months ago |
| SMA: Bullish | Jan 5, 2026 | 9 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Nov 3, 2025 | 12 months ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| SMA: Bearish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 29, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 8, 2025 | 1 year ago |
| SMA: Bullish | Sep 1, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 21, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| SMA: Bearish | Mar 24, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 24, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 20, 2025 | 1 year ago |
| RSI: Overbought | Jan 20, 2025 | 1 year ago |
| SMA: Bullish | Jan 6, 2025 | 1 year ago |
| MACD: Sell Signal | Nov 18, 2024 | 1 year ago |
| SMA: Bearish | Nov 4, 2024 | 1 year ago |
| RSI: Overbought | Sep 30, 2024 | 2 years ago |
| RSI: Overbought | Sep 9, 2024 | 2 years ago |
| RSI: Overbought | Jul 8, 2024 | 2 years ago |
| SMA: Bullish | May 20, 2024 | 2 years ago |
| MACD: Buy Signal | May 13, 2024 | 2 years ago |
| SMA: Bullish | May 6, 2024 | 2 years ago |
| RSI: Oversold | Apr 15, 2024 | 2 years ago |
| MACD: Sell Signal | Feb 26, 2024 | 2 years ago |
| SMA: Bearish | Feb 19, 2024 | 2 years ago |
| SMA: Bullish | Jan 29, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 29, 2024 | 2 years ago |
| SMA: Bearish | Jan 15, 2024 | 2 years ago |
| SMA: Bullish | Jan 8, 2024 | 2 years ago |
| SMA: Bearish | Dec 25, 2023 | 2 years ago |
| SMA: Bullish | Dec 18, 2023 | 2 years ago |
| SMA: Bearish | Nov 27, 2023 | 2 years ago |
| SMA: Bullish | Nov 20, 2023 | 2 years ago |
| SMA: Bearish | Nov 6, 2023 | 2 years ago |
| SMA: Bullish | Oct 30, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 9, 2023 | 3 years ago |
| SMA: Bearish | Sep 11, 2023 | 3 years ago |
| SMA: Bullish | Jul 10, 2023 | 3 years ago |
| SMA: Bullish | Jul 10, 2023 | 3 years ago |
| SMA: Bearish | Jun 19, 2023 | 3 years ago |
| SMA: Bullish | May 8, 2023 | 3 years ago |
| RSI: Oversold | Apr 17, 2023 | 3 years ago |
| SMA: Bearish | Feb 20, 2023 | 3 years ago |
| SMA: Bullish | Jan 9, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 9, 2023 | 3 years ago |
| RSI: Oversold | Dec 12, 2022 | 3 years ago |
| MACD: Sell Signal | Sep 26, 2022 | 4 years ago |
| SMA: Bearish | Aug 29, 2022 | 4 years ago |
| SMA: Bearish | Aug 29, 2022 | 4 years ago |
| SMA: Bullish | Jul 25, 2022 | 4 years ago |
| SMA: Bullish | Jul 4, 2022 | 4 years ago |
| SMA: Bearish | Apr 18, 2022 | 4 years ago |
| SMA: Bullish | Mar 7, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 7, 2022 | 4 years ago |
| RSI: Oversold | Dec 27, 2021 | 4 years ago |
| SMA: Bearish | Sep 20, 2021 | 5 years ago |
| SMA: Bullish | Aug 30, 2021 | 5 years ago |
| MACD: Sell Signal | Jul 19, 2021 | 5 years ago |
| SMA: Bearish | Jul 5, 2021 | 5 years ago |
| SMA: Bearish | Jul 5, 2021 | 5 years ago |
| SMA: Bullish | Jun 7, 2021 | 5 years ago |
| MACD: Buy Signal | Jun 7, 2021 | 5 years ago |
| SMA: Bullish | May 31, 2021 | 5 years ago |
| SMA: Bearish | May 10, 2021 | 5 years ago |
| SMA: Bullish | Apr 19, 2021 | 5 years ago |
| SMA: Bearish | Feb 15, 2021 | 5 years ago |
| MACD: Sell Signal | Feb 15, 2021 | 5 years ago |
| SMA: Bearish | Feb 1, 2021 | 5 years ago |
| RSI: Overbought | Dec 21, 2020 | 5 years ago |
| SMA: Bullish | Dec 7, 2020 | 5 years ago |
| SMA: Bearish | Oct 5, 2020 | 6 years ago |
| RSI: Overbought | Sep 28, 2020 | 6 years ago |
| SMA: Bullish | Aug 31, 2020 | 6 years ago |
News
1 day ago benzinga.com
This Kazia Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
Analysts initiated coverage with Buy/Overweight ratings on KZIA ($27), PSQL ($12), NSRX ($7) and LGCY ($16).
2 days ago benzinga.com
This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday
Analysts initiated bullish coverage on Rubrik, Kardigan, MSG Rangers and Ormat Technologies, with price targets of $155, $50, $257 and $123.
3 days ago benzinga.com
This Spero Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Analysts initiated coverage: Hold ALHC; Overweight/$6 SPRO; Buy/$3 LABT; Buy/$6 CLOV.
-
3 days ago benzinga.com
Needham Initiates Coverage On Clover Health Investments with Buy Rating, Announces Price Target of $6
Needham analyst Matthew Shea initiates coverage on Clover Health Investments (NASDAQ:CLOV) with a Buy rating and announces Price Target of $6.
5 days ago globenewswire.com
Clover Health to Participate in Upcoming UBS Global Healthcare Conference
WILMINGTON, Del., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Financial…
1 week ago defenseworld.net
Clover Health Investments (NASDAQ:CLOV) Insider Karen Soares Sells 14,673 Shares of Company Stock
Clover Health Investments, Corp. (NASDAQ: CLOV - Get Free Report) insider Karen Soares sold 14,673 shares of Clover Health Investments stock in a transaction on Thursday, October 15th. The stock was…
1 week ago defenseworld.net
Clover Health Investments (NASDAQ:CLOV) CEO Andrew Toy Sells 62,176 Shares of Stock
Clover Health Investments, Corp. (NASDAQ: CLOV - Get Free Report) CEO Andrew Toy sold 62,176 shares of the firm's stock in a transaction dated Thursday, October 15th. The shares were sold at an…
1 week ago defenseworld.net
Clover Health Investments (NASDAQ:CLOV) CEO Conrad Wai Sells 23,627 Shares of Stock
Clover Health Investments, Corp. (NASDAQ: CLOV - Get Free Report) CEO Conrad Wai sold 23,627 shares of the business's stock in a transaction that occurred on Thursday, October 15th. The shares were…
1 week ago globenewswire.com
Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States
WILMINGTON, Del., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health” or “Clover”), a physician enablement technology company committed to bringing…
2 weeks ago benzinga.com
QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins
UnitedHealth expects Medicaid margins to bottom in 2026 and improve through 2028, UnitedHealthcare CEO Tim Noel says on earnings call.
3 weeks ago benzinga.com
Clover Health Stock Pops: What's Happening?
Clover Health Investments shares are jumping after CMS awarded the company's Medicare Advantage plans high 2027 Star ratings.
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Humana (NYSE:HUM) stock moved upwards by 16.2% to $450.0 during Friday's pre-market session. The market value of their outstanding shares is at $46.4 billion. XORTX Therapeutics (NASDAQ:XRTX)…
3 weeks ago globenewswire.com
Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027
WILMINGTON, Del., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that the Centers for Medicare &…
3 weeks ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers SCWorx Corp. - Common Stock (NASDAQ:WORX) shares moved upwards by 48.8% to $6.25 during Thursday's after-market session. XORTX Therapeutics (NASDAQ:XRTX) stock increased by 22.7% to $2.27.…
3 weeks ago 247wallst.com
At 67, He’ll Keep His Clover Medicare Advantage Plan for 2027. The Premium Will Stay $0. The Most He Can Be Billed Will Jump $1,144
A $0 monthly premium sounds like free coverage until you read the pages most people skip. One number buried in the Annual Notice of Change quietly decides how much a serious diagnosis will actually…
3 weeks ago globenewswire.com
Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026
WILMINGTON, Del., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial…
1 month ago globenewswire.com
Clover Health's 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value
WILMINGTON, Del., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed…
1 month ago globenewswire.com
UPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D.
WILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced the appointments of former U.S.…
1 month ago globenewswire.com
Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D.
WILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) today announced the appointments of former U.S.…
1 month ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
1 month ago marketbeat.com
Clover Health Sees PPO Edge, Cohort Gains as Medicare Advantage Pricing Tightens
Clover Health Investments NASDAQ: CLOV is positioning its Medicare Advantage business to benefit from industry pricing discipline, member retention and the maturation of member cohorts, Interim Chief…
1 month ago defenseworld.net
Tidal Investments LLC Takes $2.16 Million Position in Clover Health Investments, Corp. $CLOV
Tidal Investments LLC purchased a new stake in shares of Clover Health Investments, Corp. (NASDAQ: CLOV) during the undefined quarter, according to the company in its most recent filing with the…
1 month ago defenseworld.net
Clover Health Investments (NASDAQ:CLOV) Stock Price Down 6.5% Following Insider Selling
Clover Health Investments, Corp. (NASDAQ: CLOV - Get Free Report)'s stock price fell 6.5% during trading on Tuesday after an insider sold shares in the company. The company traded as low as $4.70 and…
1 month ago benzinga.com
Wealthfront, Orchestra Biomed, AeroVironment And Other Big Stocks Moving Higher On Thursday
U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.
2 months ago globenewswire.com
Clover Health to Participate in Upcoming Investor Conferences
WILMINGTON, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following…
2 months ago seekingalpha.com
Clover Health Is A 'Buy' Because Of Its AI
Clover Health Investments, Corp. leverages its AI-powered Clover Assistant to drive lower claims costs and improve member profitability. Baseline and bullish DCF valuations yield fair values of $5.02…
2 months ago seekingalpha.com
Clover Health Investments: Real Turnaround, But Already Priced In
Clover Health Investments (CLOV) is rated Hold, with operational execution but a cautious outlook due to valuation and litigation risks. CLOV's Medicare Advantage membership grew 48% YoY, revenue and…
2 months ago seekingalpha.com
Clover Health Is Proving Its Profit Model
Clover Health (CLOV) has delivered strong growth, profitability, and improved guidance, supporting my continued Strong Buy rating. CLOV's Medicare Advantage membership grew 48% YoY, with revenue up…
2 months ago marketbeat.com
Clover Health Eyes 2026 GAAP Profit as AI Platform Fuels Medicare Advantage Growth
Clover Health Investments NASDAQ: CLOV is positioning its Medicare Advantage model around earlier identification and treatment of chronic conditions, Interim Chief Financial Officer Clay Thornton…
-
2 months ago benzinga.com
UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $5
UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and raises the price target from $4.75 to $5.
2 months ago benzinga.com
Motorola Solutions Posts Upbeat Q2 Earnings, Joins Insmed, Diodes, Parker-Hannifin And Other Big Stocks Moving Higher On Thursday
US stocks mixed on Thurs. Dow Jones down 50 pts. Motorola Solutions Inc shares up 9.5% after reporting strong Q2 results & raised guidance.
2 months ago seekingalpha.com
Clover Health Investments, Corp. (CLOV) Q2 2026 Earnings Call Transcript
Clover Health Investments, Corp. (CLOV) Q2 2026 Earnings Call Transcript
2 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday's after-market session. The company's market cap stands at $4.2 million. Caris Life Sciences…
-
2 months ago benzinga.com
Clover Health Investments Raises FY2026 Sales Guidance from $2.810B-$2.920B to $2.920B-$3.000B vs $2.910B Est
Clover Health Investments (NASDAQ:CLOV) raises FY2026 sales outlook from $2.810 billion-$2.920 billion to $2.920 billion-$3.000 billion vs $2.910 billion estimate.
-
2 months ago benzinga.com
Clover Health Investments Q2 EPS $0.05 Beats $0.03 Estimate, Sales $743.167M Beat $728.267M Estimate
Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is a 350 percent increase over losses…
-
3 months ago benzinga.com
Canaccord Genuity Maintains Buy on Clover Health Investments, Raises Price Target to $5.5
Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a Buy and raises the price target from $4.2 to $5.5.
3 months ago benzinga.com
Insurer Elevance Seeks Recalculated Medicare Star Rating in Lawsuit
Elevance sued HHS and CMS, alleging unequal Medicare Star Ratings treatment cost it about $115 million in 2027 bonus payments.
4 months ago benzinga.com
Cramer Gives Vistra His Blessing, Backs Stryker, Steers Clear Of AI-Exposed FICO
Jim Cramer endorsed Vistra, expressed caution on Fair Isaac over AI risks: "I'm not going to get in the crosshairs anymore."
-
4 months ago benzinga.com
Clover Health Investments' Clover Care Services CEO Brady Priest Stepping Down; Co. Integrating Its Home-Care Business With Its Broader Operations; Not Appointing Priest's Successor
https://www.sec.gov/ix?doc=/Archives/edgar/data/1801170/000180117026000153/clov-20260615.htm
-
4 months ago benzinga.com
UBS Maintains Neutral on Clover Health Investments, Raises Price Target to $4.75
UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and raises the price target from $2.75 to $4.75.
4 months ago benzinga.com
Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating
Clover Health shares are extending Wednesday's 18.9% surge after a court-ordered Medicare upgrade lifted its PPO plan to 4.5 Stars.
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
4 months ago benzinga.com
Caseys General Stores Upbeat Q4 Earnings, Joins Applied Optoelectronics, Clover Health Investments And Other Big Stocks Moving Higher On Wednesday
US stocks down, Dow Jones fell 150 pts on Wed. Caseys General Stores Inc (CASY) shares up 14.4% after beating earnings. Other big gainers incl. CBRL, PLBL, RXT, YB, AXTI, AAOI, LMND, CLOV, TGTX,…
-
4 months ago benzinga.com
Clover Health Announces That Its 2026 Star Rating Has Been Recalculated At 4.5 Following U.S. Court's Summary Judgement
On June 9, 2026, CMS informed Clover that, consistent with the Court's order, it has recalculated Clover's 2026 Star Rating as 4.5 Stars, and has instructed Clover to submit alternate bids at 4.5…
-
4 months ago benzinga.com
Canaccord Genuity Maintains Buy on Clover Health Investments, Raises Price Target to $4.2
Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a Buy and raises the price target from $3.2 to $4.2.
5 months ago benzinga.com
Jim Cramer Won't Recommend Mortgage Stocks Because 'I Never Know What They Really Own' — But He Loves Intel's 'Burgeoning Packaging Division'
Cramer criticizes Clover Health's quarterly results, recommends Amkor for semiconductor packaging, and expresses caution over mortgage stocks.
5 months ago benzinga.com
Lowe's, ZTO Express, Viavi Solutions And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
US stock futures higher, Lowe's shares fall after reporting earnings. Other stocks declining in pre-market trading. Photo via Shutterstock
-
5 months ago benzinga.com
Clover Health Investments Affirms FY2026 Sales Guidance of $2.810B-$2.920B vs $2.878B Est
Clover Health Investments (NASDAQ:CLOV) affirms FY2026 sales outlook from $2.810 billion-$2.920 billion to $2.810 billion-$2.920 billion vs $2.878 billion estimate.
-
5 months ago benzinga.com
Clover Health Investments Q1 EPS $0.05 Beats $0.03 Estimate, Sales $749.200M Beat $714.893M Estimate
Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. The company reported quarterly sales of…